Moomoo AI 已提取核心信息
Michael Robert A., an officer at AbbVie Inc., is set to sell 68,879 shares of the company's common stock, with an aggregate market value of approximately $12.15 million, on February 29, 2024. The shares to be sold were acquired through stock option exercises and performance shares, both as part of compensation from the issuer. On February 29, 2024, Michael Robert A. exercised stock options to acquire 21,560 shares, and on February 28, 2024, he acquired 47,319 shares through performance shares. There is no transaction history reported for the past three months prior to this notice.
Michael Robert A., an officer at AbbVie Inc., is set to sell 68,879 shares of the company's common stock, with an aggregate market value of approximately $12.15 million, on February 29, 2024. The shares to be sold were acquired through stock option exercises and performance shares, both as part of compensation from the issuer. On February 29, 2024, Michael Robert A. exercised stock options to acquire 21,560 shares, and on February 28, 2024, he acquired 47,319 shares through performance shares. There is no transaction history reported for the past three months prior to this notice.
艾伯维公司高管迈克尔·罗伯特·A定于2024年2月29日出售该公司68,879股普通股，总市值约为1,215万美元。待售股票是通过股票期权行使和绩效股票收购的，两者都是发行人薪酬的一部分。2024年2月29日，迈克尔·罗伯特·A行使股票期权收购了21,560股股票；2024年2月28日，他通过绩效股票收购了47,319股股票。在此通知之前的过去三个月中，没有报告任何交易历史记录。
艾伯维公司高管迈克尔·罗伯特·A定于2024年2月29日出售该公司68,879股普通股，总市值约为1,215万美元。待售股票是通过股票期权行使和绩效股票收购的，两者都是发行人薪酬的一部分。2024年2月29日，迈克尔·罗伯特·A行使股票期权收购了21,560股股票；2024年2月28日，他通过绩效股票收购了47,319股股票。在此通知之前的过去三个月中，没有报告任何交易历史记录。
有用
没用
